Enclomiphene Citrate HSA/FSA Eligibility and Submission: The Complete 2026 Guide

What Is Enclomiphene Citrate and Why Is It Prescribed?

Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that blocks estrogen receptors in the hypothalamus and pituitary, raising endogenous luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn stimulate testicular testosterone production. Unlike exogenous testosterone replacement therapy, enclomiphene preserves spermatogenesis, making it a preferred option for men with secondary hypogonadism who wish to maintain fertility. [1]

Mechanism of Action

Enclomiphene binds estrogen receptors in the hypothalamic-pituitary axis with higher affinity than its cis-isomer (zuclomiphene). The result is a strong pulsatile release of GnRH, followed by LH and FSH surges that drive intratesticular testosterone synthesis. A Phase III trial published in the journal Andrologia found that 25 mg daily enclomiphene normalized serum testosterone in 75% of men with secondary hypogonadism after 3 months of treatment. [2]

Approved Indications vs. Compounded Use

No FDA-approved new drug application (NDA) for enclomiphene citrate as a standalone agent existed as of January 2026. Androxal (enclomiphene citrate 12.5 mg and 25 mg), developed by Repros Therapeutics, completed Phase III trials but was not granted FDA approval. [3] Clinicians currently prescribe enclomiphene citrate through 503A compounding pharmacies (patient-specific prescriptions) or 503B outsourcing facilities. The FDA regulates these under 21 U.S.C. §§ 503A and 503B respectively. [4] Because the compound is prescribed by a licensed practitioner to treat a diagnosed condition, it meets the IRS definition of a qualifying medical expense, regardless of its compounded status.

Clinical Profile at a Glance

Serum total testosterone rises from a hypogonadal baseline (typically <300 ng/dL) to the normal male range (400 to 700 ng/dL) within 6 to 12 weeks at doses of 12.5 to 25 mg daily. A 2013 randomized trial (N=124) in The Journal of Clinical Endocrinology and Metabolism reported mean testosterone increases of 227 ng/dL from baseline in the 25 mg enclomiphene arm versus 178 ng/dL in the testosterone gel arm, with the enclomiphene group maintaining sperm counts while the gel arm showed significant suppression. [5]

IRS Rules That Govern HSA and FSA Eligibility

The Internal Revenue Service defines eligible medical expenses in Publication 502. Prescription drugs are explicitly listed as qualifying expenses. [6] The operative rule: a drug prescribed by a physician to treat a specific medical condition is eligible regardless of whether it is FDA-approved, generic, branded, or compounded, provided the prescription was issued for a legitimate medical purpose.

The "Prescribed Drug" Standard

IRS Publication 502 states that you can include in medical expenses the amount you pay for prescription drugs and insulin. A prescription written for enclomiphene citrate to treat secondary hypogonadism (ICD-10-CM code E29.1) or male infertility (ICD-10-CM code N46) satisfies this standard. [6] Your plan administrator cannot legally reject a claim solely because the drug is compounded or not FDA-approved, as long as a valid prescription exists.

HSA vs. FSA: Key Structural Differences

HSAs are paired with high-deductible health plans (HDHPs) as defined under IRS Section 223. The 2026 contribution limits are $4,300 for self-only coverage and $8,550 for family coverage. [7] FSAs are employer-sponsored accounts with a 2026 limit of $3,300. The critical operational difference is rollover: HSA balances accumulate indefinitely, while FSA funds typically expire December 31 (some plans offer a $640 grace-period carryover or a 2.5-month grace period). For a recurring monthly expense like enclomiphene, the HSA's rollover feature provides more flexibility.

Dependent Care vs. Health FSA

Only a Health FSA (not a Dependent Care FSA) covers prescription medications. Confirm with your HR department or plan documents that you are drawing from the Health FSA before submitting.

Is Compounded Enclomiphene Citrate Specifically Eligible?

Yes, with one condition: the drug must be prescribed for a diagnosed medical condition by a licensed clinician. The IRS does not distinguish between FDA-approved and compounded formulations in Publication 502. [6] The FDA's framework for 503A pharmacies requires that compounded drugs be prepared based on a valid patient-specific prescription, which is identical to the documentation standard HSA/FSA administrators require. [4]

What Plan Administrators Look For

Most third-party administrators (TPAs) use an IIAS (Inventory Information Approval System) or manual review to verify eligibility. Compounded drugs do not appear in IIAS databases because they lack a universal product code (UPC). That means your compounded enclomiphene purchase will almost always require manual review. Prepare these documents proactively:

• A copy of the original prescription or a letter of medical necessity (LMN) on clinic letterhead
• An itemized pharmacy receipt showing: drug name, dispense date, quantity, dose, and cost
• Your diagnosis code (E29.1 or N46) if the plan administrator requests it

Letter of Medical Necessity

Some flexible spending account administrators require an LMN for compounds. Your prescribing clinician should include the diagnosis, drug name, dose, expected duration, and a statement that the medication is prescribed to treat a specific medical condition rather than for general wellness. The American Academy of Clinical Endocrinology (AACE) clinical practice guidelines for male hypogonadism support the medical necessity of treatments that restore physiological testosterone levels in symptomatic men. [8]

Step-by-Step HSA/FSA Claim Submission for Enclomiphene

Submitting a claim takes roughly 10 minutes once you have the right documents in hand.

Step 1: Collect Your Documentation

Request an itemized receipt from your compounding pharmacy at the time of pickup or delivery. Ensure it shows the drug name (enclomiphene citrate), the dispensed dose (e.g., 25 mg capsules), the quantity (e.g., 30 capsules), the fill date, and the total cost paid. If your pharmacy does not automatically include all fields, ask for a supplemental invoice.

Step 2: Obtain a Prescription Record

A printed or PDF copy of the prescription itself, or a pharmacy printout confirming a valid Rx on file, is usually sufficient. If your TPA asks for more, request a letter of medical necessity from your HealthRX clinician.

Step 3: Submit the Claim

Log into your HSA or FSA plan portal. Select "Submit a Claim" or "Manual Reimbursement." Upload the itemized receipt and prescription copy. Enter the service date (the date you paid for the medication), the merchant name (the compounding pharmacy), and the dollar amount.

Step 4: Track and Follow Up

Most TPAs process manual claims within 5 to 10 business days. If your claim is denied, request a written explanation and appeal immediately. Common denial reasons include missing prescription documentation or an incomplete receipt. These are correctable on appeal.

Step 5: Keep Records for 7 Years

IRS audit rules require you to retain documentation supporting HSA/FSA withdrawals for at least 3 years from the filing date, but best practice is 7 years to cover any extended audit windows. Store digital copies in a secure folder.

How Much Can You Actually Save?

The tax savings from paying for enclomiphene with pre-tax HSA or FSA dollars depend on your effective marginal tax rate. For someone in the 22% federal bracket who also pays 5% state income tax and 7.65% FICA (if using a salary-reduction FSA), the effective savings rate approaches 34 to 35%.

Sample Savings Calculation

Assume you pay $120 per month ($1,440 per year) for compounded enclomiphene citrate. At a combined marginal rate of 32% (24% federal plus 8% state), paying through an FSA saves approximately $461 annually compared with paying after-tax. At 22% federal plus 5% state, the saving is roughly $389. These figures do not require a coupon or a manufacturer program. They are simply the tax math.

Stacking HSA/FSA With Other Discounts

You cannot use a manufacturer coupon at the same time as an HSA/FSA card for the same transaction under IRS rules. However, you can use a compounding pharmacy's cash-pay discount program to reduce the total amount, then pay the net balance with your HSA/FSA card. GoodRx and similar platforms do not typically list compounded drugs, so the most reliable discount comes from selecting an in-network compounding pharmacy or one with transparent wholesale pricing.

How to Get Compounded Enclomiphene Citrate at Lower Cost

Choose a Transparent-Pricing Pharmacy

503A compounding pharmacies set their own prices. Costs for enclomiphene citrate 25 mg (30 capsules) range from approximately $80 to $180 per month across U.S. Compounding pharmacies as of early 2026. The variance reflects overhead, raw material sourcing, and dispensing fees, not clinical differences in the compound. Asking for a price list before filling is standard and expected.

Use Your HSA/FSA First

As calculated above, pre-tax payment through an HSA or FSA cuts effective cost by 22 to 37%. This is the single most accessible discount for most patients.

Telehealth Bundled Pricing

Telehealth platforms that bundle the clinician visit, lab work, and pharmacy coordination into a monthly subscription may offer lower total cost of care than fee-for-service arrangements. Compare the all-in monthly cost (visit + labs + drug) before assuming a lower pharmacy sticker price translates to lower total spending.

Generic vs. Compounded

There is no FDA-approved generic enclomiphene product as of January 2026. Clomiphene citrate (which contains both enclomiphene and zuclomiphene isomers) is available as an FDA-approved generic at very low cost (often <$30 for 30 tablets through GoodRx). Some clinicians prescribe clomiphene as an alternative when cost is a limiting factor, though the pharmacodynamic profiles differ. [9] The choice between clomiphene and enclomiphene should be made with your clinician based on your specific labs and goals.

Special Scenarios: What If Your Claim Is Denied?

Denial for "Compounded Drug Not Eligible"

This is legally incorrect under IRS Publication 502. [6] Respond in writing with a copy of your prescription and a citation to IRS Publication 502's prescription drug definition. Most TPAs will reverse the denial on first appeal.

Denial for "Cosmetic or General Wellness"

If a reviewer misclassifies testosterone optimization as cosmetic, your LMN from a board-certified endocrinologist or urologist stating the medical diagnosis is the correct rebuttal. The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism explicitly recommends testosterone therapy for men with consistently low levels and symptoms, providing a published standard-of-care basis for medical necessity. [10]

Denial for "Prescription Not on File"

Contact your compounding pharmacy for a pharmacy-verified prescription confirmation letter. Submit this alongside the itemized receipt on appeal.

Regulatory Context: Compounded Enclomiphene and the FDA

Compounding pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act may prepare enclomiphene citrate on a patient-specific basis. 503B outsourcing facilities may produce larger batches under FDA current good manufacturing practice (CGMP) oversight. [4] Neither pathway requires an NDA, but both require the base active pharmaceutical ingredient (API) to be sourced from an FDA-registered facility.

Bulk Drug Substances List

The FDA periodically evaluates bulk drug substances for compounding under the 503A and 503B frameworks. Enclomiphene citrate has not been placed on the FDA's "difficult to compound" or "essentially a copy" lists as of January 2026, meaning compounding remains permissible. Prescribers and patients should verify current FDA guidance before initiating a new prescription. [4]

Quality and Testing

Reputable 503A pharmacies provide a certificate of analysis (COA) confirming potency, purity, and sterility (where applicable). Requesting the COA for your specific batch is reasonable and supports both safety and documentation for insurance or HSA/FSA purposes.

Clinical Monitoring While on Enclomiphene

Paying for the drug is only one part of the cost picture. Monitoring labs add to the total expense, and some are also HSA/FSA-eligible.

Recommended Lab Panel

The AACE and Endocrine Society guidelines recommend measuring serum total testosterone, LH, FSH, estradiol, and a complete blood count (CBC) at baseline and at 3-month intervals during treatment. [8, 10] Hematocrit monitoring is included because SERMs can affect erythropoiesis. Lab draws at certified diagnostic facilities are HSA/FSA-eligible medical expenses.

Target Testosterone Range

A serum total testosterone of 400 to 700 ng/dL is the general therapeutic target for symptomatic men with secondary hypogonadism, per Endocrine Society guidelines. [10] Dose adjustments between 12.5 mg and 25 mg daily are typically guided by 6-week follow-up labs.

Estradiol Management

Because enclomiphene raises LH and testosterone, estradiol may rise via aromatization. A serum estradiol above 40 pg/mL in conjunction with symptoms (gynecomastia, water retention, mood changes) may prompt the clinician to add a low-dose aromatase inhibitor such as anastrozole 0.5 mg twice weekly. This adjunct medication is also HSA/FSA-eligible when prescribed.

Frequently Asked Questions